|
1
|
Kopp F and Mendell JT: Functional
classification and experimental dissection of long noncoding RNAs.
Cell. 172:393–407. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cao H, Wahlestedt C and Kapranov P:
Strategies to annotate and characterize long noncoding RNAs:
Advantages and pitfalls. Trends Genet. 34:704–721. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kaikkonen MU and Adelman K: Emerging roles
of non-coding RNA transcription. Trends Biochem Sci. 43:654–667.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Qian X, Zhao J, Yeung PY, Zhang QC and
Kwok CK: Revealing lncRNA structures and interactions by
sequencing-based approaches. Trends Biochem Sci. 44:33–52. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xiao G, Yao J, Kong D, Ye C, Chen R, Li L,
Zeng T, Wang L, Zhang W, Shi X, et al: The Long Noncoding RNA
TTTY15, Which is located on the Y chromosome, promotes prostate
cancer progression by sponging let-7. Eur Urol. 76:315–326. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim J, Piao HL, Kim BJ, Yao F, Han Z, Wang
Y, Xiao Z, Siverly AN, Lawhon SE, Ton BN, et al: Long noncoding RNA
MALAT1 suppresses breast cancer metastasis. Nat Genet.
50:1705–1715. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang XS, Zhang Z, Wang HC, Cai JL, Xu QW,
Li MQ, Chen YC, Qian XP, Lu TJ, Yu LZ, et al: Rapid identification
of UCA1 as a very sensitive and specific unique marker for human
bladder carcinoma. Clin Cancer Res. 12:4851–4858. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cao Y, Xiong JB, Zhang GY, Liu Y, Jie ZG
and Li ZR: Long noncoding RNA UCA1 regulates PRL-3 expression by
sponging MicroRNA-495 to promote the progression of gastric cancer.
Mol Ther Nucleic Acids. 19:853–864. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang CJ, Zhu CC, Xu J, Wang M, Zhao WY,
Liu Q, Zhao G and Zhang ZZ: The lncRNA UCA1 promotes proliferation,
migration, immune escape and inhibits apoptosis in gastric cancer
by sponging anti-tumor miRNAs. Mol Cancer. 18:1152019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li O, Yi W, Yang P, Guo C and Peng C: Long
non-coding RNA UCA1 promotes proliferation and invasion of
intrahepatic cholangiocarcinoma cells through targeting
microRNA-122. Exp Ther Med. 18:25–32. 2019.PubMed/NCBI
|
|
11
|
Wang W, Hu W, Wang Y, An Y, Song L, Shang
P and Yue Z: Long non-coding RNA UCA1 promotes malignant phenotypes
of renal cancer cells by modulating the miR-182-5p/DLL4 axis as a
ceRNA. Mol Cancer. 19:182020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fan Y, Shen B, Tan M, Mu X, Qin Y, Zhang F
and Liu Y: Long non-coding RNA UCA1 increases chemoresistance of
bladder cancer cells by regulating Wnt signaling. Febs J.
281:1750–1758. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pei S, Chen J, Lu J, Hu S, Jiang L, Lei L,
Ouyang Y, Fu C, Ding Y, Li S, et al: The long noncoding RNA UCA1
negatively regulates melanogenesis in melanocytes. J Invest
Dermatol. 140:152–163.e5. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Neve B, Jonckheere N, Vincent A and Van
Seuningen I: Epigenetic Regulation by lncRNAs: An Overview Focused
on UCA1 in Colorectal Cancer. Cancers (Basel). 10:4402018.
View Article : Google Scholar
|
|
15
|
Liao K, Xu J, Yang W, You X, Zhong Q and
Wang X: The research progress of LncRNA involved in the regulation
of inflammatory diseases. Mol Immunol. 101:182–188. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liang X, Qi M, Wu R, Liu A, Chen D, Tang
L, Chen J, Hu X, Li W, Zhan L, et al: Long non-coding RNA CUDR
promotes malignant phenotypes in pancreatic ductal adenocarcinoma
via activating AKT and ERK signaling pathways. Int J Oncol.
53:2671–2682. 2018.PubMed/NCBI
|
|
17
|
Yu Y, Li M, Song Y, Xu J and Qi F:
Overexpression of long noncoding RNA CUDR promotes hepatic
differentiation of human umbilical cord mesenchymal stem cells. Mol
Med Rep. 21:1051–1058. 2020.PubMed/NCBI
|
|
18
|
Jiang CR and Li TH: Circulating UCA1 is
highly expressed in patients with systemic lupus erythematosus and
promotes the progression through the AKT pathway. Eur Rev Med
Pharmacol Sci. 22:2364–2371. 2018.PubMed/NCBI
|
|
19
|
Shi CH, Huang Y, Li WQ and Chen RG:
Influence of LncRNA UCA1 on glucose metabolism in rats with
diabetic nephropathy through PI3K-Akt signaling pathway. Eur Rev
Med Pharmacol Sci. 23:10058–10064. 2019.PubMed/NCBI
|
|
20
|
Cai L, Tu L, Li T, Yang X, Ren Y, Gu R,
Zhang Q, Yao H, Qu X, Wang Q and Tian J: Downregulation of lncRNA
UCA1 ameliorates the damage of dopaminergic neurons, reduces
oxidative stress and inflammation in Parkinson's disease through
the inhibition of the PI3K/Akt signaling pathway. Int
Immunopharmacol. 75:1057342019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu J, Li W, Ning J, Yu W, Rao T and Cheng
F: Long noncoding RNA UCA1 targets miR-582-5p and contributes to
the progression and drug resistance of bladder cancer cells through
ATG7-mediated autophagy inhibition. Onco Targets Ther. 12:495–508.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bian Z, Jin L, Zhang J, Yin Y, Quan C, Hu
Y, Feng Y, Liu H, Fei B, Mao Y, et al: LncRNA-UCA1 enhances cell
proliferation and 5-fluorouracil resistance in colorectal cancer by
inhibiting miR-204-5p. Sci Rep. 6:238922016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao B, Lu Y, Cao X, Zhu W, Kong L, Ji H,
Zhang F, Lin X, Guan Q, Ou K, et al: MiRNA-124 inhibits the
proliferation, migration and invasion of cancer cell in
hepatocellular carcinoma by downregulating lncRNA-UCA1. Onco
Targets Ther. 12:4509–4516. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Luan Y, Li X, Luan Y, Zhao R, Li Y, Liu L,
Hao Y, Oleg Vladimir B and Jia L: Circulating lncRNA UCA1 promotes
malignancy of colorectal cancer via the miR-143/MYO6 Axis. Mol Ther
Nucleic Acids. 19:790–803. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li F and Hu CP: Long Non-Coding RNA
urothelial carcinoma associated 1 (UCA1): Insight into its role in
human diseases. Crit Rev Eukaryot Gene Expr. 25:191–197. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li N, Cui M, Yu P and Li Q: Correlations
of lncRNAs with cervical lymph node metastasis and prognosis of
papillary thyroid carcinoma. Onco Targets Ther. 12:1269–1278. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu Y, Feng W, Gu S, Wang H, Zhang Y, Chen
W, Xu W, Lin C, Gong A and Xu M: The UCA1/KRAS axis promotes human
pancreatic ductal adenocarcinoma stem cell properties and tumor
growth. Am J Cancer Res. 9:496–510. 2019.PubMed/NCBI
|
|
28
|
Chen L, Cao P, Wu Q, Guo Y, Yang Y and
Chen F: Overexpression of LncRNA-UCA1 correlates with lung
adenocarcinoma progression and poor Prognosis. Clin Lab. 65:2019.
View Article : Google Scholar
|
|
29
|
Lee JJ, Kim M and Kim HP: Epigenetic
regulation of long noncoding RNA UCA1 by SATB1 in breast cancer.
BMB Rep. 49:578–583. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Guo X, Zhang Y, Mayakonda A, Madan V, Ding
LW, Lin LH, Zia S, Gery S, Tyner JW, Zhou W, et al: ARID1A and
CEBPα cooperatively inhibit UCA1 transcription in breast cancer.
Oncogene. 37:5939–5951. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sadek KM, Lebda MA, Nasr NE, Nasr SM and
El-Sayed Y: Role of lncRNAs as prognostic markers of hepatic cancer
and potential therapeutic targeting by S-adenosylmethionine via
inhibiting PI3K/Akt signaling pathways. Environ Sci Pollut Res Int.
25:20057–20070. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xue M, Li X, Wu W, Zhang S, Wu S, Li Z and
Chen W: Upregulation of long non-coding RNA urothelial carcinoma
associated 1 by CCAAT/enhancer binding protein alpha contributes to
bladder cancer cell growth and reduced apoptosis. Oncol Rep.
31:1993–2000. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li GY, Wang W, Sun JY, Xin B, Zhang X,
Wang T, Zhang QF, Yao LB, Han H, Fan DM, et al: Long non-coding
RNAs AC026904.1 and UCA1: A ‘one-two punch’ for TGF-β-induced SNAI2
activation and epithelial-mesenchymal transition in breast cancer.
Theranostics. 8:2846–2861. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jin B, Gong Y, Li H, Jiao L, Xin D, Gong
Y, He Z, Zhou L, Jin Y, Wang X, et al: C/EBPβ promotes the
viability of human bladder cancer cell by contributing to the
transcription of bladder cancer specific lncRNA UCA1. Biochem
Biophys Res Commun. 506:674–679. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wu W, Zhang S, Li X, Xue M, Cao S and Chen
W: Ets-2 regulates cell apoptosis via the Akt pathway, through the
regulation of urothelial cancer associated 1, a long non-coding
RNA, in bladder cancer cells. PLoS One. 8:e739202013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang ZQ, Cai Q, Hu L, He CY, Li JF, Quan
ZW, Liu BY, Li C and Zhu ZG: Long noncoding RNA UCA1 induced by SP1
promotes cell proliferation via recruiting EZH2 and activating AKT
pathway in gastric cancer. Cell Death Dis. 8:e28392017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cui X, Zhao C, Yao X, Qian B, Su C, Ren Y,
Yao Z, Gao X and Yang J: SND1 acts as an anti-apoptotic factor via
regulating the expression of lncRNA UCA1 in hepatocellular
carcinoma. RNA Biol. 15:1364–1375. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Su Y, Zhou Y, Sun YJ, Wang YL, Yin JY,
Huang YJ, Zhang JJ, He AN, Han K, Zhang HZ, et al:
Macrophage-derived CCL18 promotes osteosarcoma proliferation and
migration by upregulating the expression of UCA1. J Mol Med (Berl).
97:49–61. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bourguignon LYW: Matrix hyaluronan-CD44
interaction activates MicroRNA and LncRNA Signaling Associated With
chemoresistance, invasion, and tumor progression. Front Oncol.
9:4922019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hung YP, Redig A, Hornick JL and Sholl LM:
ARID1A mutations and expression loss in non-small cell lung
carcinomas: Clinicopathologic and molecular analysis. Mod Pathol.
33:2256–2268. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang T, Gao X, Zhou K, Jiang T, Gao S, Liu
P, Zuo X and Shi X: Role of ARID1A in epithelial-mesenchymal
transition in breast cancer and its effect on cell sensitivity to
5-FU. Int J Mol Med. 46:1683–1694. 2020.PubMed/NCBI
|
|
42
|
Ferri-Borgogno S, Barui S, McGee AM,
Griffiths T, Singh PK, Piett CG, Ghosh B, Bhattacharyya S, Singhi
A, Pradhan K, et al: Paradoxical Role of AT-rich interactive domain
1a in restraining pancreatic carcinogenesis. Cancers (Basel).
12:26952020. View Article : Google Scholar
|
|
43
|
Kumar PP, Emechebe U, Smith R, Franklin S,
Moore B, Yandell M, Lessnick SL and Moon AM: Coordinated control of
senescence by lncRNA and a novel T-box3 co-repressor complex.
Elife. 3:e028052014. View Article : Google Scholar
|
|
44
|
Huang J, Zhou N, Watabe K, Lu Z, Wu F, Xu
M and Mo YY: Long non-coding RNA UCA1 promotes breast tumor growth
by suppression of p27 (Kip1). Cell Death Dis. 5:e10082014.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhou Y, Meng X, Chen S, Li W, Li D, Singer
R and Gu W: IMP1 regulates UCA1-mediated cell invasion through
facilitating UCA1 decay and decreasing the sponge effect of UCA1
for miR-122-5p. Breast Cancer Res. 20:322018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhang TH, Liang LZ, Liu XL, Wu JN, Su K,
Chen JY and Zheng QY: LncRNA UCA1/miR-124 axis modulates
TGFβ1-induced epithelial-mesenchymal transition and invasion of
tongue cancer cells through JAG1/Notch signaling. J Cell Biochem.
120:10495–10504. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Hiemer SE, Szymaniak AD and Varelas X: The
transcriptional regulators TAZ and YAP direct transforming growth
factor beta-induced tumorigenic phenotypes in breast cancer cells.
J Biol Chem. 289:13461–13474. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Guo J, Li Y, Duan H and Yuan L: Metformin
suppresses the proliferation and promotes the apoptosis of colon
cancer cells through inhibiting the expression of long noncoding
RNA-UCA1. Onco Targets Ther. 13:4169–4181. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Li T, Sun X and Jiang X: UCA1 involved in
the metformin-regulated bladder cancer cell proliferation and
glycolysis. Tumour Biol. 39:10104283177108232017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Guo M, Zhou JJ and Huang W: Metformin
alleviates endometrial hyperplasia through the
UCA1/miR144/TGFbeta1/AKT signaling pathway. Int J Mol Med.
45:623–633. 2020.PubMed/NCBI
|
|
51
|
Ding Y, Yuan X, Gu W and Lu L: Treatment
with metformin prevents pre-eclampsia by suppressing migration of
trophoblast cells via modulating the signaling pathway of
UCA1/miR-204/MMP-9. Biochem Biophys Res Commun. 520:115–121. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zha Z, Han Q, Liu W and Huo S: lncRNA
GAS8-AS1 downregulates lncRNA UCA1 to inhibit osteosarcoma cell
migration and invasion. J Orthop Surg Res. 15:382020. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zhou Y, Li Y, Wang N, Li X, Zheng J and Ge
L: UPF1 inhibits the hepatocellular carcinoma progression by
targeting long non-coding RNA UCA1. Sci Rep. 9:66522019. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Pan J, Dai Q, Zhang T and Li C: Palmitate
acid promotes gastric cancer metastasis via FABP5/SP1/UCA1 pathway.
Cancer Cell Int. 19:692019. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Jahangiri B, Khalaj-Kondori M, Asadollahi
E and Sadeghizadeh M: Cancer-associated fibroblasts enhance cell
proliferation and metastasis of colorectal cancer SW480 cells by
provoking long noncoding RNA UCA1. J Cell Commun Signal. 13:53–64.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Hu JJ, Song W, Zhang SD, Shen XH, Qiu XM,
Wu HZ, Gong PH, Lu S, Zhao ZJ, He ML and Fan H: HBx-upregulated
lncRNA UCA1 promotes cell growth and tumorigenesis by recruiting
EZH2 and repressing p27Kip1/CDK2 signaling. Sci Rep. 6:235212016.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Lv S, Yuan P, Lu C, Dong J, Li M, Qu F,
Zhu Y and Zhang J: QiShenYiQi pill activates autophagy to attenuate
reactive myocardial fibrosis via the PI3K/AKT/mTOR pathway. Aging
(Albany NY). Feb 11–2021.(Epub ahead of print). doi:
10.18632/aging.202482. View Article : Google Scholar
|
|
58
|
Zhou S, Zhu Y, Li Z, Zhu Y, He Z and Zhang
C: Exosome-derived long non-coding RNA ADAMTS9-AS2 suppresses
progression of oral submucous fibrosis via AKT signalling pathway.
J Cell Mol Med. 25:2262–2273. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Goyal B, Yadav SRM, Awasthee N, Gupta S,
Kunnumakkara AB and Gupta SC: Diagnostic, prognostic, and
therapeutic significance of long non-coding RNA MALAT1 in cancer.
Biochim Biophys Acta Rev Cancer. 1875:1885022021. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Ghafouri-Fard S, Abak A, Tondro Anamag F,
Shoorei H, Majidpoor J and Taheri M: The emerging role of
non-coding RNAs in the regulation of PI3K/AKT pathway in the
carcinogenesis process. Biomed Pharmacother. 137:1112792021.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Xin H, Liu N, Xu X, Zhang J, Li Y, Ma Y,
Li G and Liang J: Knockdown of lncRNA-UCA1 inhibits cell viability
and migration of human glioma cells by miR-193a-mediated
downregulation of CDK6. J Cell Biochem. 120:15157–15169. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Sun MD, Zheng YQ, Wang LP, Zhao HT and
Yang S: Long noncoding RNA UCA1 promotes cell proliferation,
migration and invasion of human leukemia cells via sponging
miR-126. Eur Rev Med Pharmacol Sci. 22:2233–2245. 2018.PubMed/NCBI
|
|
63
|
Sun S, Wu Y, Guo W, Yu F, Kong L, Ren Y,
Wang Y, Yao X, Jing C, Zhang C, et al: STAT3/HOTAIR signaling axis
regulates HNSCC growth in an EZH2-dependent manner. Clin Cancer
Res. 24:2665–2677. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Yang R, Wang M, Zhang G, Bao Y, Wu Y, Li
X, Yang W and Cui H: E2F7-EZH2 axis regulates PTEN/AKT/mTOR
signalling and glioblastoma progression. Br J Cancer.
123:1445–1455. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Han H, Wang S, Meng J, Lyu G, Ding G, Hu
Y, Wang L, Wu L, Yang W, Lv Y, et al: Long noncoding RNA PART1
restrains aggressive gastric cancer through the epigenetic
silencing of PDGFB via the PLZF-mediated recruitment of EZH2.
Oncogene. 39:6513–6528. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Cha TL, Zhou BP, Xia W, Wu Y, Yang CC,
Chen CT, Ping B, Otte AP and Hung MC: Akt-mediated phosphorylation
of EZH2 suppresses methylation of lysine 27 in histone H3. Science.
310:306–310. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Chen P, Wan D, Zheng D, Zheng Q, Wu F and
Zhi Q: Long non-coding RNA UCA1 promotes the tumorigenesis in
pancreatic cancer. Biomed Pharmacother. 83:1220–1226. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Yang C, Li X, Wang Y, Zhao L and Chen W:
Long non-coding RNA UCA1 regulated cell cycle distribution via CREB
through PI3-K dependent pathway in bladder carcinoma cells. Gene.
496:8–16. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Wang X, Gong Y, Jin B, Wu C, Yang J, Wang
L, Zhang Z and Mao Z: Long non-coding RNA urothelial carcinoma
associated 1 induces cell replication by inhibiting BRG1 in 5637
cells. Oncol Rep. 32:1281–1290. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Pan J, Li X, Wu W, Xue M, Hou H, Zhai W
and Chen W: Long non-coding RNA UCA1 promotes cisplatin/gemcitabine
resistance through CREB modulating miR-196a-5p in bladder cancer
cells. Cancer Lett. 382:64–76. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Li T, Xiao Y and Huang T: HIF1-α-ainduced
upregulation of lncRNA UCA1 promotes cell growth in osteosarcoma by
inactivating the PTEN/AKT signaling pathway. Oncol Rep.
39:1072–1080. 2018.PubMed/NCBI
|
|
72
|
Ma H, Su R, Feng H, Guo Y and Su G: Long
noncoding RNA UCA1 promotes osteosarcoma metastasis through
CREB1-mediated epithelial-mesenchymal transition and activating
PI3K/AKT/mTOR pathway. J Bone Oncol. 16:1002282019. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Wu ZR, Yan L, Liu YT, Cao L, Guo YH, Zhang
Y, Yao H, Cai L, Shang HB, Rui WW, et al: Inhibition of mTORC1 by
lncRNA H19 via disrupting 4E-BP1/Raptor interaction in pituitary
tumours. Nat Commun. 9:46242018. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Wu C and Luo J: Long non-coding RNA
(lncRNA) urothelial carcinoma-associated 1 (UCA1) enhances
tamoxifen resistance in breast cancer cells via inhibiting mTOR
signaling pathway. Med Sci Monit. 22:3860–3867. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Popova NV and Jücker M: The Role of mTOR
Signaling as a Therapeutic Target in Cancer. Int J Mol Sci.
22:17432021. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Zhang Z, Li H, Cui Z, Zhou Z, Chen S, Ma
J, Hou L, Pan X and Li Q: Long non-coding RNA UCA1 relieves
cardiomyocytes H9c2 injury aroused by oxygen-glucose deprivation
via declining miR-122. Artif Cells Nanomed Biotechnol.
47:3492–3499. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Wang QS, Zhou J and Li X: LncRNA UCA1
protects cardiomyocytes against hypoxia/reoxygenation induced
apoptosis through inhibiting miR-143/MDM2/p53 axis. Genomics.
112:574–580. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Zhang J and Zhang C: Silence of long
non-coding RNA UCA1 inhibits hemangioma cells growth, migration and
invasion by up-regulation of miR-200c. Life Sci. 226:33–46. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Li Z, Li X, Wu S, Xue M and Chen W: Long
non-coding RNA UCA1 promotes glycolysis by upregulating hexokinase
2 through the mTOR-STAT3/microRNA143 pathway. Cancer Sci.
105:951–955. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
van Andel H, Kocemba KA, Spaargaren M and
Pals ST: Aberrant Wnt signaling in multiple myeloma: molecular
mechanisms and targeting options. Leukemia. 33:1063–1075. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Zhang B, Fang S, Cheng Y, Zhou C and Deng
F: The long non-coding RNA, urothelial carcinoma associated 1,
promotes cell growth, invasion, migration, and chemo-resistance in
glioma through Wnt/β-catenin signaling pathway. Aging (Albany NY).
11:8239–8253. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Lu HW and Liu XD: UCA1 promotes papillary
thyroid carcinoma development by stimulating cell proliferation via
Wnt pathway. Eur Rev Med Pharmacol Sci. 22:5576–5582.
2018.PubMed/NCBI
|
|
83
|
Liu H, Wang G, Yang L, Qu J, Yang Z and
Zhou X: Knockdown of long non-coding RNA UCA1 increases the
tamoxifen sensitivity of breast cancer cells through inhibition of
Wnt/β-Catenin Pathway. PLoS One. 11:e01684062016. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Chen X, Gao J, Yu Y, Zhao Z and Pan Y:
Long non-coding RNA UCA1 targets miR-185-5p and regulates cell
mobility by affecting epithelial-mesenchymal transition in melanoma
via Wnt/β-catenin signaling pathway. Gene. 676:298–305. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Zhu G, Liu X, Su Y, Kong F, Hong X and Lin
Z: Knockdown of urothelial carcinoma-associated 1 suppressed cell
growth and migration through regulating miR-301a and CXCR4 in
osteosarcoma MHCC97 Cells. Oncol Res. 27:55–64. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Chen T, Chen Z, Lian X, Wu W, Chu L, Zhang
S and Wang L: MUC 15 promotes osteosarcoma cell proliferation,
migration and invasion through livin, MMP-2/MMP-9 and Wnt/β-catenin
signal pathway. J Cancer. 12:467–473. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Gui X, Li H, Li T, Pu H and Lu D: Long
Noncoding RNA CUDR regulates HULC and β-catenin to govern human
liver stem cell malignant differentiation. Mol Ther. 23:1843–1853.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Lombard DB, Cierpicki T and Grembecka J:
Combined MAPK Pathway and HDAC Inhibition Breaks Melanoma. Cancer
Discov. 9:469–471. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Kong L, Wu Q, Zhao L, Ye J, Li N and Yang
H: Upregulated lncRNA-UCA1 contributes to metastasis of bile duct
carcinoma through regulation of miR-122/CLIC1 and activation of the
ERK/MAPK signaling pathway. Cell Cycle. 18:1212–1228. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Li D, Hao S and Zhang J: Long non-coding
RNA UCA1 exerts growth modulation by miR-15a in human thyroid
cancer TPC-1 cells. Artif Cells Nanomed Biotechnol. 47:1815–1822.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Nixon CC, Mavigner M, Sampey GC, Brooks
AD, Spagnuolo RA, Irlbeck DM, Mattingly C, Ho PT, Schoof N, Cammon
CG, et al: Systemic HIV and SIV latency reversal via non-canonical
NF-κB signalling in vivo. Nature. 578:160–165. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Zheng Q, Lin Z, Li X, Xin X, Wu M, An J,
Gui X, Li T, Pu H, Li H and Lu D: Inflammatory cytokine IL6
cooperates with CUDR to aggravate hepatocyte-like stem cells
malignant transformation through NF-κB signaling. Sci Rep.
6:368432016. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Yu Q, Zhao MW and Yang P: LncRNA UCA1
suppresses the inflammation via modulating miR-203-mediated
regulation of MEF2C/NF-κB signaling pathway in epilepsy. Neurochem
Res. 45:783–795. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Qin L, Jia Z, Xie D and Liu Z: Knockdown
of long noncoding RNA urothelial carcinoma-associated 1 inhibits
cell viability, migration, and invasion by regulating microRNA-182
in gastric carcinoma. J Cell Biochem. 119:10075–10086. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
95
|
de Bock CE, Demeyer S, Degryse S, Verbeke
D, Sweron B, Gielen O, Vandepoel R, Vicente C, Vanden Bempt M,
Dagklis A, et al: HOXA9 cooperates with activated JAK/STAT
signaling to drive leukemia development. Cancer Discov. 8:616–631.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Jiang H, Zhu M, Wang H and Liu H:
Suppression of lncRNA MALAT1 reduces pro-inflammatory cytokines
production by regulating miR-150-5p/ZBTB4 axis through JAK/STAT
signal pathway in systemic juvenile idiopathic arthritis. Cytokine.
138:1553972021. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Yang W, Qian Y, Gao K, Zheng W, Wu G, He
Q, Chen Q, Song Y, Wang L, Wang Y, et al: LncRNA BRCAT54 inhibits
the tumorigenesis of non-small cell lung cancer by binding to RPS9
to transcriptionally regulate JAK-STAT and calcium pathway genes.
Carcinogenesis. 42:80–92. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Li JL, Liu XL, Guo SF, Yang Y, Zhu YL and
Li JZ: Long noncoding RNA UCA1 regulates proliferation and
apoptosis in multiple myeloma by targeting miR-331-3p/IL6R axis for
the activation of JAK2/STAT3 pathway. Eur Rev Med Pharmacol Sci.
23:9238–9250. 2019.PubMed/NCBI
|
|
99
|
Liu J, Luo C, Zhang C, Cai Q, Lin J, Zhu T
and Huang X: Upregulated lncRNA UCA1 inhibits trophoblast cell
invasion and proliferation by downregulating JAK2. J Cell Physiol.
235:7410–7419. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Wang H, Yao G, Li L, Ma Z, Chen J and Chen
W: LncRNA-UCA1 inhibits the astrocyte activation in the temporal
lobe epilepsy via regulating the JAK/STAT signaling pathway. J Cell
Biochem. 121:4261–4270. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Xu J, Shao T, Song M, Xie Y, Zhou J, Yin
J, Ding N, Zou H, Li Y and Zhang J: MIR22HG acts as a tumor
suppressor via TGFβ/SMAD signaling and facilitates immunotherapy in
colorectal cancer. Mol Cancer. 19:512020. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Zhang ZS, Wang J, Zhu BQ and Ge L: Long
noncoding RNA UCA1 promotes multiple myeloma cell growth by
targeting TGF-beta. Eur Rev Med Pharmacol Sci. 22:1374–1379.
2018.PubMed/NCBI
|
|
103
|
Shu T, He L, Wang X, Pang M, Yang B, Feng
F, Wu Z, Liu C, Zhang S, Liu B, et al: Long noncoding RNA UCA1
promotes chondrogenic differentiation of human bone marrow
mesenchymal stem cells via miRNA-145-5p/SMAD5 and
miRNA-124-3p/SMAD4 axis. Biochem Biophys Res Commun. 514:316–322.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Li Z, Liu H, Zhong Q, Wu J and Tang Z:
LncRNA UCA1 is necessary for TGF-β-induced epithelial-mesenchymal
transition and stemness via acting as a ceRNA for Slug in glioma
cells. FEBS Open Bio. 8:1855–1865. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Zhang M, Zhao Y, Zhang Y, Wang D, Gu S,
Feng W, Peng W, Gong A and Xu M: LncRNA UCA1 promotes migration and
invasion in pancreatic cancer cells via the Hippo pathway. Biochim
Biophys Acta Mol Basis Dis. 1864:1770–1782. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Tian Y, Zhang X, Hao Y, Fang Z and He Y:
Potential roles of abnormally expressed long noncoding RNA UCA1 and
Malat-1 in metastasis of melanoma. Melanoma Res. 24:335–341. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Liu Q, Li Y, Lv W, Zhang G, Tian X, Li X,
Cheng H and Zhu C: UCA1 promotes cell proliferation and invasion
and inhibits apoptosis through regulation of the miR129-SOX4
pathway in renal cell carcinoma. Onco Targets Ther. 11:2475–2487.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Duan Q, Xu M, Wu M, Zhang X, Gan M and
Jiang H: Long noncoding RNA UCA1 promotes cell growth, migration,
and invasion by targeting miR-143-3p in oral squamous cell
carcinoma. Cancer Med. 9:3115–3129. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Li ZG, Xiang WC, Shui SF, Han XW, Guo D
and Yan L: 11 Long noncoding RNA UCA1 functions as miR-135a sponge
to promote the epithelial to mesenchymal transition in glioma. J
Cell Biochem. 121:2447–2457. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Sun S, Gong C and Yuan K: LncRNA UCA1
promotes cell proliferation, invasion and migration of laryngeal
squamous cell carcinoma cells by activating Wnt/β-catenin signaling
pathway. Exp Ther Med. 17:1182–1189. 2019.PubMed/NCBI
|
|
111
|
Chen X, Wang Z, Tong F, Dong X, Wu G and
Zhang R: lncRNA UCA1 Promotes Gefitinib Resistance as a ceRNA to
Target FOSL2 by Sponging miR-143 in Non-small Cell Lung Cancer. Mol
Ther Nucleic Acids. 19:643–653. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
He C, Lu X, Yang F, Qin L, Guo Z, Sun Y
and Wu J: LncRNA UCA1 acts as a sponge of miR-204 to up-regulate
CXCR4 expression and promote prostate cancer progression. Biosci
Rep. 39:BSR201814652019. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Han R, Chen S, Wang J, Zhao Y and Li G:
LncRNA UCA1 affects epithelial-mesenchymal transition, invasion,
migration and apoptosis of nasopharyngeal carcinoma cells. Cell
Cycle. 18:3044–3053. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Yu Y, Gao F, He Q, Li G and Ding G: lncRNA
UCA1 functions as a ceRNA to promote prostate cancer progression
via sponging miR143. Mol Ther Nucleic Acids. 19:751–758. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Gharib E, Anaraki F, Baghdar K, Ghavidel
P, Sadeghi H, Nasrabadi PN, Peyravian N, Aghdaei HA, Zali MR and
Mojarad EN: Investigating the diagnostic performance of HOTTIP,
PVT1, and UCA1 long noncoding RNAs as a predictive panel for the
screening of colorectal cancer patients with lymph node metastasis.
J Cell Biochem. 120:14780–14790. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Esfandi F, Taheri M, Kholghi Oskooei V and
Ghafouri-Fard S: Long noncoding RNAs expression in gastric cancer.
J Cell Biochem. 120:13802–13809. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Pan J, Xie X, Li H, Li Z, Ren C and Ming
L: Detection of serum long non-coding RNA UCA1 and circular RNAs
for the diagnosis of bladder cancer and prediction of recurrence.
Int J Clin Exp Pathol. 12:2951–2958. 2019.PubMed/NCBI
|
|
118
|
Hu ML, Wang XY and Chen WM: TGF-β1
upregulates the expression of lncRNA UCA1 and its downstream HXK2
to promote the growth of hepatocellular carcinoma. Eur Rev Med
Pharmacol Sci. 22:4846–4854. 2018.PubMed/NCBI
|
|
119
|
Zheng ZK, Pang C, Yang Y, Duan Q, Zhang J
and Liu WC: Serum long noncoding RNA urothelial
carcinoma-associated 1: A novel biomarker for diagnosis and
prognosis of hepatocellular carcinoma. J Int Med Res. 46:348–356.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Mirzajani S, Ghafouri-Fard S, Habibabadi
JM, Arsang-Jang S, Omrani MD, Fesharaki SSH, Sayad A and Taheri M:
Expression analysis of lncRNAs in refractory and non-refractory
epileptic patients. J Mol Neurosci. 70:689–698. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Yu X, Wang R, Han C, Wang Z and Jin X: A
panel of urinary long non-coding RNAs differentiate bladder cancer
from urocystitis. J Cancer. 11:781–787. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Mahvi DA, Liu R, Grinstaff MW, Colson YL
and Raut CP: Local cancer recurrence: The realities, challenges,
and opportunities for new therapies. CA Cancer J Clin. 68:488–505.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Yao F, Wang Q and Wu Q: The prognostic
value and mechanisms of lncRNA UCA1 in human cancer. Cancer Manag
Res. 11:7685–7696. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Guo N, Sun Q, Fu D and Zhang Y: Long
non-coding RNA UCA1 promoted the growth of adrenocortical cancer
cells via modulating the miR-298-CDK6 axis. Gene. 703:26–34. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Kang K, Huang YH, Li HP and Guo SM:
Expression of UCA1 and MALAT1 long-chain non-coding RNAs in
esophageal squamous cell carcinoma tissues is predictive of patient
prognosis. Arch Med Sci. 14:752–759. 2018.PubMed/NCBI
|
|
126
|
Tang X, Yu L, Bao J, Jiang P and Yan F:
Function of long noncoding RNA UCA1 on gastric cancer cells and its
clinicopathological significance in plasma. Clin Lab. Nov
1–2019.(Epub ahead of print). doi: 10.7754/Clin.Lab.2019.181233.
View Article : Google Scholar
|
|
127
|
Yang L, Zhang L, Lu L and Wang Y: lncRNA
UCA1 increases proliferation and multidrug resistance of
retinoblastoma cells through downregulating miR-513a-5p. DNA Cell
Biol. 39:69–77. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Wang J, Ye C, Liu J and Hu Y: UCA1 confers
paclitaxel resistance to ovarian cancer through miR-129/ABCB1 axis.
Biochem Biophys Res Commun. 501:1034–1040. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Zhang Y, Liu Y and Xu X: Knockdown of
LncRNA-UCA1 suppresses chemoresistance of pediatric AML by
inhibiting glycolysis through the microRNA-125a/hexokinase 2
pathway. J Cell Biochem. 119:6296–6308. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Yang YN, Zhang R, Du JW, Yuan HH, Li YJ,
Wei XL, Du XX, Jiang SL and Han Y: Predictive role of
UCA1-containing exosomes in cetuximab-resistant colorectal cancer.
Cancer Cell Int. 18:1642018. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Zhu HY, Bai WD, Ye XM, Yang AG and Jia LT:
Long non-coding RNA UCA1 desensitizes breast cancer cells to
trastuzumab by impeding miR-18a repression of Yes-associated
protein 1. Biochem Biophys Res Commun. 496:1308–1313. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Xiao Y, Jiao C, Lin Y, Chen M, Zhang J,
Wang J and Zhang Z: lncRNA UCA1 contributes to imatinib resistance
by acting as a ceRNA against miR-16 in chronic myeloid leukemia
cells. DNA Cell Biol. 36:18–25. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Wang X, Yang B and Ma B: The
UCA1/miR-204/Sirt1 axis modulates docetaxel sensitivity of prostate
cancer cells. Cancer Chemother Pharmacol. 78:1025–1031. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Zhen S, Lu J, Chen W, Zhao L and Li X:
Synergistic antitumor effect on bladder cancer by rational
combination of programmed cell death 1 blockade and
CRISPR-Cas9-mediated long non-coding RNA urothelial carcinoma
associated 1 knockout. Hum Gene Ther. 29:1352–1363. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Misale S, Yaeger R, Hobor S, Scala E,
Janakiraman M, Liska D, Valtorta E, Schiavo R, Buscarino M,
Siravegna G, et al: Emergence of KRAS mutations and acquired
resistance to anti-EGFR therapy in colorectal cancer. Nature.
486:532–536. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Liang F, Ren C, Wang J, Wang S, Yang L,
Han X, Chen Y, Tong G and Yang G: The crosstalk between STAT3 and
p53/RAS signaling controls cancer cell metastasis and cisplatin
resistance via the Slug/MAPK/PI3K/AKT-mediated regulation of EMT
and autophagy. Oncogenesis. 8:592019. View Article : Google Scholar : PubMed/NCBI
|
